← Every applicant

Tianjin Huahong Technology Co., Ltd. FDA Approvals

0 new drug approvals and 16 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
Safety lancet (XL)510(k)Sep 13, 2026General, Plastic Surgery
Lancing device510(k)Aug 18, 2026General, Plastic Surgery
Huahong Sharps Container (HHR-I, HHR-II)510(k)Aug 5, 2026General Hospital
Lancet510(k)Jul 22, 2026General, Plastic Surgery
Safety lancet (XXXVII)510(k)Mar 31, 2026General, Plastic Surgery
Heel Stick Safety Lancet (HHZ-II, HHZ-III, HHZ-IV)510(k)Feb 12, 2026General, Plastic Surgery
Lancing device (HH-XV-T)510(k)Dec 9, 2025General, Plastic Surgery
safety lancet510(k)Jun 26, 2025General, Plastic Surgery
Lancet (IA, IB, IC, ID, IE, IK, IL, IM, IIA, IIB, III, V, VI, VII, VIII, IX); Lancing device (HH-X-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T, HH-XXV-T, HH-XXVI-T, HH-XXVIII-T, HH-XXIX-T, HH-XXX-T, HH-XIII-T, HH-XXVII-T)510(k)Nov 15, 2024General, Plastic Surgery
Safety Lancet (XXXV)510(k)Jun 20, 2024General, Plastic Surgery
Safety lancet (XXVIII, XXIX, XXX, XXXI, XXXII, XXXIII, XXXIV.)510(k)May 21, 2024General, Plastic Surgery
Lancet (I, II, III, V, VI); Lancing device (HH-X-T, HH-XIII-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T)510(k)Jul 6, 2022General, Plastic Surgery
Insulin Pen Needle510(k)Jul 1, 2022General Hospital
Safety Lancet (XIII, XVII, XXI, XXII, XXIII, XXIV, XXV, XXVI)510(k)May 19, 2022General, Plastic Surgery
Heel Stick Safety Lancet (HHZ-II, HHZ-III)510(k)May 17, 2022General, Plastic Surgery
Insulin Pen Needle (Ordinary Type), Insulin Pen Needle (Safety Type)510(k)Nov 12, 2021General Hospital

Related datasets